Scienture Holdings SCNX
NASDAQ SCNX
$2.77 -0.13 (-4.65%)
At close: Oct 22, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Equity Income (2019)

Updated

Scienture Holdings (SCNX) recorded Equity Income of -$58,850 in Q2 2019.

Analysis

Scienture Holdings (SCNX) Equity Income (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -10.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Scienture Holdings 4.36 Mn -12.56 Mn 335,779.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -58,850.00
Mar 31, 2019 -28,972.00
API Access

Scienture Holdings Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=SCNX&period=max&api_key=YOUR_API_KEY